Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Influenza

  Free Subscription


20.11.2017

3 BMJ
1 J Clin Microbiol
1 J Gen Virol
1 J Infect Dis
1 J Virol
2 J Virol Methods
1 Pediatrics
1 PLoS Comput Biol
4 PLoS One
7 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMJ


  1. How can we prepare better for influenza epidemics?
    BMJ. 2017;359:j5271.
    PubMed     Text format    

  2. DYER C
    Irish MP calls for key documents on Pandemrix to be handed to lawyers representing children with narcolepsy.
    BMJ. 2017;357:j1959.
    PubMed     Text format    

  3. GULLAND A
    Sixty seconds on . . . flu.
    BMJ. 2017;356:j1268.
    PubMed     Text format    


    J Clin Microbiol

  4. COHEN DM, Kline J, May LS, Harnett GE, et al
    Accurate PCR Detection of Influenza A/B and RSV Using the Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu.
    J Clin Microbiol. 2017 Nov 15. pii: JCM.01237-17. doi: 10.1128/JCM.01237.
    PubMed     Text format     Abstract available


    J Gen Virol

  5. NYKVIST M, Gillman A, Soderstrom Lindstrom H, Tang C, et al
    In vivo mallard experiments indicate that zanamivir has less potential for environmental influenza A virus resistance development than oseltamivir.
    J Gen Virol. 2017 Nov 15. doi: 10.1099/jgv.0.000977.
    PubMed     Text format     Abstract available


    J Infect Dis

  6. SEON SH, Choi JA, Yang E, Pyo S, et al
    Intranasal Immunization with an Attenuated Pep27 Mutant Provides Protection from Influenza Virus and Secondary Pneumococcal Infections.
    J Infect Dis. 2017 Nov 14. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Virol

  7. TE VELTHUIS AJW, Oymans J
    Initiation, elongation and realignment during influenza virus mRNA synthesis.
    J Virol. 2017 Nov 15. pii: JVI.01775-17. doi: 10.1128/JVI.01775.
    PubMed     Text format     Abstract available


    J Virol Methods

  8. LIU J, Yao L, Zhai F, Chen Y, et al
    Development and application of a triplex real-time PCR assay for the simultaneous detection of avian influenza virus subtype H5, H7 and H9.
    J Virol Methods. 2017 Nov 9. pii: S0166-0934(17)30361.
    PubMed     Text format     Abstract available

  9. WILLE M, Yin H, Lundkvist A, Xu J, et al
    RNAlater(R) is a viable storage option for avian influenza sampling in logistically challenging conditions.
    J Virol Methods. 2017;252:32-36.
    PubMed     Text format     Abstract available


    Pediatrics

  10. BOYCE TG, Yogev R, DeVincenzo JP, Krilov LR, et al
    Confounding by Indication Limits Conclusions of Study of Palivizumab Effectiveness.
    Pediatrics. 2017;139.
    PubMed     Text format    


    PLoS Comput Biol

  11. SHAMAN J, Kandula S, Yang W, Karspeck A, et al
    The use of ambient humidity conditions to improve influenza forecast.
    PLoS Comput Biol. 2017;13:e1005844.
    PubMed     Text format     Abstract available


    PLoS One

  12. CHANG CK, Chen CJ, Wu CC, Chen SW, et al
    Cellular hnRNP A2/B1 interacts with the NP of influenza A virus and impacts viral replication.
    PLoS One. 2017;12:e0188214.
    PubMed     Text format     Abstract available

  13. CLARK AM, DeDiego ML, Anderson CS, Wang J, et al
    Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
    PLoS One. 2017;12:e0188267.
    PubMed     Text format     Abstract available

  14. BUCHAN SA, Chung H, Campitelli MA, Crowcroft NS, et al
    Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada.
    PLoS One. 2017;12:e0187834.
    PubMed     Text format     Abstract available

  15. SAVIC M, Dembinski JL, Laake I, Hungnes O, et al
    Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy.
    PLoS One. 2017;12:e0188055.
    PubMed     Text format     Abstract available


    Vaccine

  16. CROUSE QUINN S, Jamison AM, Freimuth VS, An J, et al
    Determinants of influenza vaccination among high-risk Black and White adults.
    Vaccine. 2017 Nov 7. pii: S0264-410X(17)31491.
    PubMed     Text format     Abstract available

  17. OHANNESSIAN R, Yaghobian S, Verger P, Vanhems P, et al
    A systematic review of serious video games used for vaccination.
    Vaccine. 2016 Aug 3. pii: S0264-410X(16)30646.
    PubMed     Text format     Abstract available

  18. PILLSBURY A, Quinn H, Cashman P, Leeb A, et al
    Active SMS-based influenza vaccine safety surveillance in Australian children.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31499.
    PubMed     Text format     Abstract available

  19. PUIG-BARBERA J, Guglieri-Lopez B, Tortajada-Girbes M, Lopez-Labrador FX, et al
    Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31529.
    PubMed     Text format     Abstract available

  20. COLE KS, Martin JM, Horne WT, Lin CJ, et al
    Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Vaccine. 2017 Nov 10. pii: S0264-410X(17)31235.
    PubMed     Text format     Abstract available

  21. AINSLIE KEC, Shi M, Haber M, Orenstein WA, et al
    On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Vaccine. 2017 Nov 13. pii: S0264-410X(17)31539.
    PubMed     Text format     Abstract available

  22. PAN Y, Wang Q, Yang P, Zhang L, et al
    Influenza vaccination in preventing outbreaks in schools: A long-term ecological overview.
    Vaccine. 2017 Nov 8. pii: S0264-410X(17)31525.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: